Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Moderna rallies after BofA raises its price target to $24 from $21

Summary by sherwood.news
Moderna is best known for being tapped by the US government to quickly develop a vaccine for COVID-19 in 2020, which remains its single source of revenue.

1 Articles

sherwood.newssherwood.news
Lean Left

Moderna rallies after BofA raises its price target to $24 from $21

Moderna is best known for being tapped by the US government to quickly develop a vaccine for COVID-19 in 2020, which remains its single source of revenue.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

sherwood.news broke the news in on Tuesday, January 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Rallies icon

Rallies

Vaccines icon

Vaccines

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal